To meet the specific challenges of biopharmaceutical development, we have a team of scientists with expertise in immunochemistry, cell based assays and LC-MS/MS (BioMSTM) approaches for this important class of therapeutic agent.
Our capabilities and experience includes recombinant proteins, vaccines, blood products, monoclonal antibodies, oligonucleotides and gene therapy products.
Biopharmaceutical development programmes
Development and validation of bioanalytical assays to support your biopharmaceutical development programme, whether it be Pharmacokinetic (PK), Anti-Drug-Antibody (ADA), Neutralising Antibodies (nAbs) or Pharmacodynamic (PD) is core to our business.
Our bioanalytical services for biopharmaceuticals include:
- New method development
- Method validation (GLP, GCP or non-regulated)
- Sample analysis to support discovery, preclinical and clinical programmes
- Macromolecule quantification and characterisation to support biopharmaceutical development and manufacture.
Experienced, qualified staff and investment in the latest technologies allow us to provide high quality bioanalytical services for biopharmaceuticals in support of all stages of your development.